Related Experiment Video
Updated: May 3, 2026

In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease
Published on: December 20, 2017
Beta-glucuronidase and Beta-glucosidase activity in stool specimens of children with inflammatory bowel disease
Marta Mroczyńska1, Miroslawa Galecka2, Patrycja Szachta2
1Institute of Fermentation Technology and Microbiology, Technical University of Lódi, Poland.
Insights
Children with Inflammatory Bowel Diseases (IBD) show significantly lower beta-glucuronidase activity in stool compared to healthy children. Beta-glucosidase activity did not differ significantly between the groups.
Area of Science:
- Gastroenterology
- Pediatrics
- Microbiology
Background:
- Inflammatory Bowel Diseases (IBD) encompass chronic conditions affecting the gastrointestinal tract in children.
- Gut microbiome alterations, including enzyme activity, are implicated in IBD pathogenesis.
- Beta-glucuronidase and beta-glucosidase are key enzymes produced by gut bacteria.
Purpose of the Study:
- To investigate differences in fecal beta-glucuronidase and beta-glucosidase activity between children with IBD and healthy controls.
- To explore correlations between enzyme activity, disease activity (PCDAI, Truelove-Witts scales), and age.
Main Methods:
- Stool specimens were collected from pediatric patients diagnosed with IBD and age-matched healthy children.
- Enzyme activity of beta-glucuronidase and beta-glucosidase was quantified using spectrophotometry.
- Disease activity was assessed using the Pediatric Crohn's Disease Activity Index (PCDAI) and the Truelove-Witts scale.
Main Results:
- Beta-glucosidase activity in stool did not significantly differ between children with IBD and healthy controls.
- A significant correlation between beta-glucosidase activity and age was observed in healthy children, but not in the IBD group.
- Fecal beta-glucuronidase activity was approximately two times lower in children with IBD compared to healthy children.
- Beta-glucuronidase activity showed a significant correlation with age in children with IBD, unlike in the healthy cohort.
Conclusions:
- Reduced fecal beta-glucuronidase activity may serve as a potential biomarker in pediatric IBD.
- Age-related changes in gut enzyme activity differ between healthy children and those with IBD.
- Further research is warranted to elucidate the role of specific bacterial enzymes in IBD pathophysiology.
Abstract:
The aim of the study was to analyze the differences in the activity of beta-glucuronidase and beta-glucosidase in stool specimens of children with Inflammatory Bowel Diseases (IBD) and healthy subjects. The disease activity was determined according to the PCDAI scale (Crohn disease) and Truelove-Witts scale (Ulcerative colitis). Enzyme activity was determined by spectrophotometry. There was a correlation between the level of beta - glucosidase activity in stool and patient's age in the group of healthy controls, but not in the IBD group. beta-glucosidase activity in IBD and healthy subjects stool specimens did not differ significantly. The activity of beta-glucuronidase in children with IBD was two times lower than in the healthy group and was correlated with age in children with IBD, but not in the group of healthy ones.
Related Concept Videos
Serum Laboratory Studies, Stool Test, Breath Test
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...

